Essentials of model-informed drug development (MIDD) top-down versus bottom-up approaches



About the Event

Join AusBiotech to learn about the essentials of Model-informed drug development (MIDD) approaches, including population pharmacokinetics (popPK) and physiologically-based pharmacokinetics (PBPK). The experts will illustrate the application of each technology with case studies, and discuss how MIDD helps drug developers save time and money.

To overcome the unique challenges that drug discovery and development process presents (including long lead-times and being capital intensive), Certara supports the entire biopharma R&D process with its gold-standard biosimulation software and technology-enabled services. Importantly, it helps to reduce cycle times, lower costs, and improve outcomes for patients.